Search results
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases.
Jul 11, 2023 · Princeton, N.J. – July 11, 2023 – Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company based in Japan, today announces the completion of its new North America headquarters at 510 Carnegie Center in Princeton, NJ.
Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases...
Across North America and around the globe, Kyowa Kirin strives to create and deliver novel medicines with life-changing value. We are a Japan-based global specialty pharmaceutical company that uses cutting-edge science to address the needs of patients across multiple therapeutic areas.
Learn how we deliver medicines in the following therapeutic areas: neurology, immunology & allergy, oncology, and nephrology. Our commitment to breakthroughs and research expertise is aimed at advancing treatment paradigms and understanding of diseases.
Jun 23, 2021 · North America’s share of Kyowa Kirin’s total revenue jumped last year to 19% from 13%, surpassing Europe-Middle-East-Africa (EMEA) to become Kyowa Kirin’s second largest region for revenue...
Mar 31, 2021 · Kyowa Kirin Integrates North America Businesses in Support of Company's 2030 Vision and Rapid Growth Trajectory. New Organizational Structure and Senior Leadership Hires Seek to Strengthen...
